ReviewJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2010
Epidemiology of thymoma and associated malignancies.
Review in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 327 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
327 citing papers in PubMed, 599 citations in OpenAlex.
- Multi-modal prediction model for thymic epithelial tumors: Enhancing surgical decisions and recurrence risk assessment from CT datasets.European journal of radiology open · 2026Article
- Myasthenia Gravis and Thymoma.Muscle & nerve · 2026Review
- Preoperative Jugulofemoral Shunting in Complex Extended Thymectomy-Anesthetic Optimization for Invasive Thymoma.Annals of thoracic surgery short reports · 2026Article
- Article
- A comparison of robot-assisted thoracic surgery and median sternotomy for the treatment of early-stage thymoma: a propensity score matching study.General thoracic and cardiovascular surgery · 2026Article
- Validation of the Ninth Edition TNM Classification for Thymic Carcinoma After Complete Resection in a High-Volume Center.JTO clinical and research reports · 2026Article
- Initial chemotherapy decreases transfusion dependence and enables definitive therapy in metastatic thymoma complicated by pure red cell aplasia: A case report.Oncology letters · 2026Article
- A Rare Histologic Variant of Thymoma: Diagnostic Challenges of Micronodular Thymoma With Lymphoid Stroma.Cureus · 2026Article
- Patterns of care in the use of radiotherapy for thymoma: a TROD thoracic oncology working group survey (TROD 08-013).Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Article
- Thymoma in the United States (2000-2023): Population-Based Incidence, Treatment Patterns, and Survival.Cureus · 2026Article
- Postoperative radiotherapy improves overall survival and was not associated with a statistically significant increase in cardiac-specific mortality in thymoma patients: a propensity score-matched analysis of the SEER database.Journal of thoracic disease · 2026Article
- Multiple lung metastases from typical type A thymoma after long-term follow-up: a case report.Journal of cardiothoracic surgery · 2026Article
- Synchronous Bilateral Breast Cancer and Thymoma: A Rare Case of Multiple Primary Malignancies.Clinical case reports · 2026Article
- Nationwide trends in mediastinal tumor and myasthenia gravis surgery in Japan: a decade claims-based analysis (2014-2023).International journal of clinical oncology · 2026Article
- Second primary malignancy risk after thymic epithelial tumors: a Surveillance, Epidemiology, and End Results analysis integrating multiple primary-standardized incidence ratio and competing-risk models.Journal of thoracic disease · 2026Article
- Long-Term Outcomes of Surgical Resection for Thymic Epithelial Tumour With Intrathoracic Dissemination.Interdisciplinary cardiovascular and thoracic surgery · 2026Article
- When Central Tolerance Fails: Thymic Malignancies at the Intersection of Cancer Immunity and Autoimmunity.Cancers · 2026Review
- Characterization of tumour microenvironment in thymic epithelial tumours of different histological subtypes.Discover oncology · 2026Article
- Association of hospital volume with perioperative and long-term outcomes of minimally invasive thymectomy.JTCVS open · 2026Article
- Long-Term Response Without Immune-Related Adverse Events to Atezolizumab Treatment in TMB-High Thymoma: A Case Report from the KOSMOS-II Study.Journal of clinical medicine · 2026Article
267 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
Abstract
backgroundThymoma is a rare malignancy of unknown etiology.
methodsThe author examined patterns in thymoma incidence in the US general population using data from Surveillance, Epidemiology, and End Results (SEER) cancer registries. Prior studies concerning the risk of additional malignancies in thymoma patients were reviewed.
resultsBased on cancer registry data, the overall incidence of thymoma in the US is 0.13 per 100,000 person-years. Thymoma is exceedingly uncommon in children and young adults, rises in incidence in middle age, and peaks in the seventh decade of life. Thymoma incidence is especially high among Asians and Pacific Islanders in the US. While several studies based at single treatment centers have suggested that thymoma patients have a broadly increased risk for other malignancies, follow up data from US cancer registries support a more limited spectrum of cancer risk. In particular, thymoma patients have a subsequently elevated risk for developing B-cell non-Hodgkin's lymphoma. Based on limited data, thymoma patients may also have an elevated risk for developing soft tissue sarcomas. DISCUSSION: Thymoma is a rare malignancy. The excess risk for non-Hodgkin's lymphoma is consistent with an effect of immune disturbance arising from the thymoma or its treatment. While descriptive epidemiologic data may yield clues to the etiology of thymoma, large multi-center case-control studies will be required to formally evaluate environmental and genetic risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.